US Stem Cell Inc
OTC:USRM
US Stem Cell Inc
OTC:USRM
Price:
0.0001
USD
Market Cap:
$64.2k
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
US Stem Cell Inc
OTC:USRM
|
US |
|
Q
|
Qualcomm Inc
XETRA:QCI
|
US |
|
Bang & Olufsen A/S
OTC:BGOUF
|
DK |
|
L
|
London Stock Exchange Group PLC
OTC:LNSTY
|
UK |
|
Juli Sling Co Ltd
SZSE:002342
|
CN |
|
S
|
Sri Lotus Developers and Realty Ltd
NSE:LOTUSDEV
|
IN |
|
Motivating Masses Inc
OTC:MNMT
|
US |
|
S
|
Shanghai Bio-heart Biological Technology Co Ltd
HKEX:2185
|
CN |
|
Alliance Nickel Ltd
OTC:AXNLF
|
AU |
|
N
|
Northview Acquisition Corp
NASDAQ:NVAC
|
US |
Balance Sheet
Balance Sheet Decomposition
US Stem Cell Inc
US Stem Cell Inc
Balance Sheet Decomposition is not available for
US Stem Cell Inc
US Stem Cell Inc
Balance Sheet
US Stem Cell Inc
US Stem Cell Inc
Currency: USD
| Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Cash & Cash Equivalents |
5
|
5
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
5
|
5
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
5
|
5
|
6
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
0
|
0
|
0
|
0
|
|
| PP&E Net |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
1
|
5
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
6
N/A
|
7
+11%
|
11
+74%
|
2
-84%
|
2
+1%
|
0
-83%
|
0
-13%
|
0
-41%
|
0
-44%
|
0
+128%
|
0
+12%
|
0
+87%
|
2
+274%
|
2
+14%
|
0
-95%
|
0
-2%
|
0
-42%
|
0
+33%
|
|
| Liabilities | |||||||||||||||||||
| Accounts Payable |
0
|
1
|
2
|
2
|
2
|
2
|
2
|
4
|
2
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
|
| Accrued Liabilities |
0
|
1
|
5
|
5
|
4
|
4
|
4
|
1
|
4
|
2
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
5
|
5
|
5
|
6
|
5
|
2
|
3
|
2
|
2
|
3
|
4
|
3
|
4
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
7
|
8
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
3
|
3
|
4
|
4
|
|
| Other Current Liabilities |
1
|
1
|
1
|
0
|
1
|
1
|
1
|
4
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
|
| Total Current Liabilities |
1
|
2
|
14
|
15
|
10
|
11
|
12
|
14
|
13
|
11
|
6
|
6
|
6
|
6
|
9
|
11
|
12
|
14
|
|
| Long-Term Debt |
0
|
0
|
3
|
1
|
5
|
1
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
3
|
1
|
1
|
1
|
1
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
1
N/A
|
2
+72%
|
17
+665%
|
16
-4%
|
15
-5%
|
12
-19%
|
12
0%
|
15
+20%
|
14
-6%
|
11
-20%
|
8
-28%
|
8
+6%
|
9
+3%
|
9
+0%
|
10
+10%
|
12
+22%
|
13
+10%
|
15
+16%
|
|
| Equity | |||||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Retained Earnings |
51
|
65
|
83
|
97
|
101
|
106
|
111
|
115
|
118
|
120
|
122
|
124
|
128
|
130
|
134
|
137
|
140
|
143
|
|
| Additional Paid In Capital |
56
|
69
|
77
|
83
|
87
|
94
|
99
|
100
|
104
|
110
|
115
|
116
|
120
|
123
|
124
|
124
|
127
|
127
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
5
N/A
|
4
-6%
|
6
N/A
|
14
-158%
|
13
+6%
|
12
+10%
|
12
+0%
|
15
-22%
|
14
+6%
|
11
+21%
|
8
+29%
|
8
-4%
|
7
+11%
|
7
+3%
|
9
-38%
|
12
-22%
|
13
-10%
|
15
-16%
|
|
| Total Liabilities & Equity |
6
N/A
|
7
+11%
|
11
+74%
|
2
-84%
|
2
+1%
|
0
-83%
|
0
-13%
|
0
-41%
|
0
-44%
|
0
+128%
|
0
+12%
|
0
+87%
|
2
+274%
|
2
+14%
|
0
-95%
|
0
-2%
|
0
-42%
|
0
+33%
|
|
| Shares Outstanding | |||||||||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
127
|
342
|
378
|
418
|
436
|
504
|
634
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
20
|
20
|
20
|
20
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
